Which cholesterol are we measuring with the Roche direct, homogeneous LDL-C Plus assay?
Ordóñez-Llanos, J.; Wägner, A.M.; Bonet-Marqués, R.; Sánchez-Quesada, J.L.; Blanco-Vaca, F.; González-Sastre, F.
Clinical Chemistry 47(1): 124-126
2001
ISSN/ISBN: 0009-9147 PMID: 11148187 Document Number: 539139
Document emailed within 1 workday
Related Documents
Nauck, M.; März, W.; Haas, B.; Wieland, H. 1996: Homogeneous assay for direct determination of high-density lipoprotein cholesterol evaluated Clinical Chemistry 42(3): 424-429Leowattana, W.; Narkrung, S.; Pokum, S.; Kiartivich, S. 2000: Analytical and clinical performance of two homogeneous assays for measuring of LDL-cholesterol Journal of the Medical Association of Thailand 83(Suppl 2): S6-12
Yamada, K.; Tsuji, N.; Fujita, T.; Tanaka, M.; Kuribasyashi, K.; Kobayashi, D.; Watanabe, N. 2010: Comparison of Four Direct Homogeneous Methods for the Measurement of Low-Density Lipoprotein Cholesterol Clinical Laboratory 56(7-8): 327-333
Kim, H.; Oh, E.-J.; Kang, M.-S.; Kim, S.H.; Park, Y.-J. 2007: Comparison of the Abbott Architect i2000 assay, the Roche Modular Analytics E170 assay, and an immunoradiometric assay for serum hepatitis B virus markers Annals of Clinical and Laboratory Science 37(3): 256-259
Matsushima, T. 2007: Methods for direct assay of low density lipoprotein cholesterol Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 7): 153-158
Ng, T.K. 1993: Blood cholesterol screening: influence of fasting state, biological variation and the single cholesterol assay on total cholesterol level Medical Journal of Malaysia 48(1): 12-16
Rule, A.H.; Nathanson, L.; Binder, S.; Miller, H.H. 1976: Comparison of cea-roche "indirect" and "direct" radioimmunoassays: a second look New England Journal of Medicine 295(19): 1079-1080
Miida, T.; Hirayama, S. 2012: LDL-cholesterol homogeneous assays versus Friedewald's equation Rinsho Byori. Japanese Journal of Clinical Pathology 60(4): 323-327
Ekins, R. 1992: One-step, labeled-antibody assay for measuring free thyroxine. 1. Assay development and validation Clinical Chemistry 38(11): 2355-2358
Fanari, Z.; Grove, M.; Rajamanickam, A.; Hammami, S.; Walls, C.; Kolm, P.; Saltzberg, M.; Weintraub, W.S.; Doorey, A.J. 2016: The Impact of Direct Cardiac Output Determination on Using a Widely Available Direct Continuous Oxygen Consumption Measuring Device on the Hemodynamic Assessment of Aortic Valve Delaware Medical Journal 88(9): 270-275
Takenokuchi, M.; Yasuda, C.; Nakamachi, Y.; Mukai, M.; Yoon, S.; Kondoh, S.; Kumagai, S. 2002: Comparative evaluation of serum HCV RNA by Roche Monitor Assay. Versions 1.0 and 2.0; as a predictive marker of subsequent response to IFN therapy Rinsho Byori. Japanese Journal of Clinical Pathology 50(4): 392-397
Blake, D.A.; Skarstedt, M.T.; Shultz, J.L.; Wilson, D.P. 1984: Zymogen activation: a new system for homogeneous ligand-binding assay Clinical Chemistry 30(9): 1452-1456
Bowden, D.W.; Rising, M.; Akots, G.; Myles, A.; Broeze, R.J. 1986: Homogeneous, liposome-based assay for total complement activity in serum Clinical Chemistry 32(2): 275-278
Descotes, J.; Peyrethon, D.; Bes, J.; Belleville, J. 1972: A profile of the risk of direct arterial surgery in the lower limbs. Evaluation based on the homogeneous statistics of 810 operations Lyon Medical 227(9): 793-796
Michael Fahie-Wilson; Bieglmayer, C.; Jürgen Kratzsch; Nusbaumer, C.; Heinz Jürgen Roth; Zaninotto, M.; Plebani, M.; Hubbuch, A.; Schneider, E. 2007: Roche Elecsys Prolactin II assay: Reactivity with Macroprolactin Compared with Eight Commercial Assays for Prolactin and Determination of Monomeric Prolactin by Precipitation with Polyethylene Glycol Clinical Laboratory 53(5-6): 301-307
Chou, C.-H.; Hsu, H.-L.; Lee, L.-N.; Hsueh, P.-R.; Luh, K.-T. 2009: Comparison of 2 interferon-gamma assays and Roche Cobas Amplicor Mycobacterium tuberculosis assay for rapid diagnosis of tuberculosis among patients with suspected tuberculosis in Taiwan Journal of Microbiology Immunology and Infection 42(3): 251-257
Ram, N.; Ahmed, B.; Hashmi, F.; Jabbar, A. 2014: Importance of measuring non-HDL cholesterol in type 2 diabetes patients Jpma. Journal of the Pakistan Medical Association 64(2): 124-128
Simon, K.; Kowalewski, W.; Dobracki, W. 1987: Evaluation of the indicators of arteriosclerosis risk factors: cholesterol:HDL cholesterol and LDL cholesterol: HDL cholesterol in acute and chronic diseases of the liver Przeglad Lekarski 44(11): 746-750
Tria, M.; Ku, L.; Abrahams, I. 1978: Noise reduction in an AutoAnalyzer Ii direct cholesterol method Clinical Chemistry 24(1): 168
Fricke, O.; Stabrey, A.; Schoenau, E. 2000: Chemiluminescence Immunometric Assay for Measuring Osteocalcin in Healthy Children Clinical Laboratory 46(5-6): 281-284